Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Noctrix Health has raised $40.0M in total funding. The most recent round was Series C. The last funding was announced in January 2024.
Noctrix Health's investors include OrbiMed, ResMed, Bolt, Angelini Ventures, LivaNova.
Noctrix Health is headquartered in San Francisco, United States.
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Noctrix Health is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Noctrix Health — Funding & Investors." VCBacked, January 16, 2024, https://www.vcbacked.co/company/noctrix-health. Accessed August 1, 2026.
VCBacked. (2024). Noctrix Health — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/noctrix-health
{{cite web |title=Noctrix Health — Funding & Investors |url=https://www.vcbacked.co/company/noctrix-health |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated